Company News

January 31, 2013 at 2:57AM

NEW PRODUCTS

St. Jude Medical Inc., Little Canada, announced the enrollment of the first patient in the EnligHTN II trial. This post-market clinical study will further evaluate the safety and efficacy of the EnligHTN Renal Denervation System in patients with uncontrolled hypertension.

about the writer

about the writer

More from Business

See More
card image
Aaron Lavinsky/The Minnesota Star Tribune

New York-based investment firm Taconic Capital and developer Polaris Properties were optimistic after the 17-story west tower’s renovation completed in late 2024. But tenants were hard to land.

card image
card image